Gurugram (Haryana) [India], December 27 (ANI/BusinessWire India): India is now facing a significant burden from the rising cancer incidence rate, which is continually climbing. According to estimates, India will record 19 to 20 lakh cancer cases by the end of 2022, although the actual incide
A randomised clinical trial has found that treating pancreatic cancer patients with chemotherapy before surgery significantly improved 1-year survival rates compared to immediate surgery.
After two years of chemotherapy treatment, nine out of ten children are cured. But some children have a more aggressive form of the disease. For example, children with a so-called Ikaros change in the DNA of their leukaemia cells have a greater risk of their disease coming back after treatme
Washington State University-led research indicates that a common chemotherapy drug could carry a toxic inheritance for children and grandchildren of adolescent cancer survivors.
The urge to vomit after eating contaminated food is the body's natural defensive response to get rid of bacterial toxins. However, the process of how our brain initiates this biological reaction upon detecting germs remains elusive.
Researchers found and developed nanoparticles that simultaneously carry chemotherapy and a new immunotherapy. Chemotherapy is a pillar of cancer treatment, but residual cancer cells can persist and cause tumor relapse.
Researchers from the University of Pittsburgh have designed cancer-fighting nanoparticles that co-deliver a chemotherapy drug and a novel immunotherapy.
A protein that can predict whether or not DNA-damaging treatments will be effective when it is found in high concentrations in breast cancer tumors, according to researchers.
Scientists have identified a drug that could be a game-changer for patients. Istradefylline, which is already approved for Parkinson's disease, could reduce not only the harmful effects of cisplatin but also improve its anti-tumour properties.
Blood stem cell transplantation is a radical but highly effective therapy for multiple sclerosis. A study has now examined in detail the way in which the treatment curbs the autoimmune disease and how the immune system regenerates afterward. A better understanding of these mechanisms should